In regards to pediatric studies, the cut-off value of FLT3/ITD AR was only reported by two large-scale collaboration groups, which were the Children’s Oncology Group (COG) with 630 childhood patients, and Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) with a total of 369 samples. This evidence concerns the gene FLT3 and lymphoma.